{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T19:45:09Z","timestamp":1777923909826,"version":"3.51.4"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2015,11,23]],"date-time":"2015-11-23T00:00:00Z","timestamp":1448236800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Tumor Biol."],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1007\/s13277-015-4420-0","type":"journal-article","created":{"date-parts":[[2015,11,23]],"date-time":"2015-11-23T09:14:23Z","timestamp":1448270063000},"page":"5971-5978","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Prognostic significance of \u03b22-adrenergic receptor expression in malignant melanoma"],"prefix":"10.1007","volume":"37","author":[{"given":"Akira","family":"Shimizu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyoichi","family":"Kaira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keita","family":"Mori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Madoka","family":"Kato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kimihiro","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahito","family":"Yasuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayumi","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsunari","family":"Oyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takayuki","family":"Asao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Osamu","family":"Ishikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,11,23]]},"reference":[{"key":"4420_CR1","doi-asserted-by":"publisher","first-page":"a015388","DOI":"10.1101\/cshperspect.a015388","volume":"4","author":"EB Hawryluk","year":"2014","unstructured":"Hawryluk EB, Tsao H. Melanoma: clinical features and genomic insights. Cold Spring Harb Perspect Med. 2014;4:a015388. doi: 10.1101\/cshperspect.a015388 .","journal-title":"Cold Spring Harb Perspect Med"},{"key":"4420_CR2","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1016\/j.bjps.2010.07.006","volume":"63","author":"JR Marsden","year":"2010","unstructured":"Marsden JR, Newton-Bishop JA, Burrows L, Cook M, Corrie PG, Cox NH, et al. Revised UK guidelines for the management of cutaneous melanoma 2010. J Plast Reconstr Aesthet Surg JPRAS. 2010;63:1401\u201319.","journal-title":"J Plast Reconstr Aesthet Surg JPRAS"},{"key":"4420_CR3","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/jid.2009.177","volume":"130","author":"KS Smalley","year":"2010","unstructured":"Smalley KS. Understanding melanoma signaling networks as the basis for molecular targeted therapy. J Invest Dermatol. 2010;130:28\u201337.","journal-title":"J Invest Dermatol"},{"key":"4420_CR4","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1038\/nature00766","volume":"417","author":"H Davies","year":"2002","unstructured":"Davies H, Bignell GR, Cox C, Stephens P, Edkins S, Clegg S, et al. Mutations of the BRAF gene in human cancer. Nature. 2002;417:949\u201354.","journal-title":"Nature"},{"key":"4420_CR5","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1016\/j.cellsig.2014.06.016","volume":"26","author":"A Wnorowski","year":"2014","unstructured":"Wnorowski A, Jozwiak K. Homo- and hetero-oligomerization of \u03b22-adrenergic receptor in receptor trafficking, signaling pathways and receptor pharmacology. Cell Signal. 2014;26:2259\u201365.","journal-title":"Cell Signal"},{"key":"4420_CR6","doi-asserted-by":"crossref","first-page":"2599","DOI":"10.1517\/14656566.2010.482561","volume":"11","author":"WS Aronow","year":"2010","unstructured":"Aronow WS. Current role of beta-blockers in the treatment of hypertension. Expert Opin Pharmacother. 2010;11:2599\u2013607.","journal-title":"Expert Opin Pharmacother"},{"key":"4420_CR7","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/j.1365-2133.2010.09848.x","volume":"163","author":"CH Storch","year":"2010","unstructured":"Storch CH, Hoeger PH. Propranolol for infantile haemangiomas: insights into the molecular mechanisms of action. Br J Dermatol. 2010;163:269\u201374.","journal-title":"Br J Dermatol"},{"key":"4420_CR8","first-page":"2866","volume":"61","author":"K Masur","year":"2001","unstructured":"Masur K, Niggemann B, Zanker KS, Entschladen F. Norepinephrine-induced migration of SW 480 colon carcinoma cells is inhibited by beta-blockers. Cancer Res. 2001;61:2866\u20139.","journal-title":"Cancer Res"},{"key":"4420_CR9","doi-asserted-by":"crossref","first-page":"2744","DOI":"10.1002\/ijc.21723","volume":"118","author":"D Palm","year":"2006","unstructured":"Palm D, Lang K, Niggemann B, Drell 4th TL, Masur K, Zaenker KS, et al. The norepinephrine-driven metastasis development of PC-3 human prostate cancer cells in BALB\/c nude mice is inhibited by beta-blockers. Int J Cancer J Int Cancer. 2006;118:2744\u20139.","journal-title":"Int J Cancer J Int Cancer"},{"key":"4420_CR10","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/j.1600-0714.2008.00691.x","volume":"38","author":"ZJ Shang","year":"2009","unstructured":"Shang ZJ, Liu K, de Liang F. Expression of beta2-adrenergic receptor in oral squamous cell carcinoma. J Oral Pathol Med: Off Publ Int Assoc Oral Pathol Am Acad Oral Pathol. 2009;38:371\u20136.","journal-title":"J Oral Pathol Med: Off Publ Int Assoc Oral Pathol Am Acad Oral Pathol"},{"key":"4420_CR11","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1158\/1078-0432.CCR-05-1698","volume":"12","author":"AK Sood","year":"2006","unstructured":"Sood AK, Bhatty R, Kamat AA, Landen CN, Han L, Thaker PH, et al. Stress hormone-mediated invasion of ovarian cancer cells. Clin Cancer Res: Off J Am Assoc Cancer Res. 2006;12:369\u201375.","journal-title":"Clin Cancer Res: Off J Am Assoc Cancer Res"},{"key":"4420_CR12","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.bbi.2008.10.005","volume":"23","author":"EV Yang","year":"2009","unstructured":"Yang EV, Kim SJ, Donovan EL, Chen M, Gross AC, Webster Marketon JI, et al. Norepinephrine upregulates VEGF, IL-8, and IL-6 expression in human melanoma tumor cell lines: implications for stress-related enhancement of tumor progression. Brain Behav Immun. 2009;23:267\u201375.","journal-title":"Brain Behav Immun"},{"key":"4420_CR13","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1200\/JCO.2010.33.4441","volume":"29","author":"A Melhem-Bertrandt","year":"2011","unstructured":"Melhem-Bertrandt A, Chavez-Macgregor M, Lei X, Brown EN, Lee RT, Meric-Bernstam F, et al. Beta-blocker use is associated with improved relapse-free survival in patients with triple-negative breast cancer. J Clin Oncol: Off J Am Soc Clin Oncol. 2011;29:2645\u201352.","journal-title":"J Clin Oncol: Off J Am Soc Clin Oncol"},{"key":"4420_CR14","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1200\/JCO.2010.33.5422","volume":"29","author":"TI Barron","year":"2011","unstructured":"Barron TI, Connolly RM, Sharp L, Bennett K, Visvanathan K. Beta blockers and breast cancer mortality: a population- based study. J Clin Oncol: Off J Am Soc Clin Oncol. 2011;29:2635\u201344.","journal-title":"J Clin Oncol: Off J Am Soc Clin Oncol"},{"key":"4420_CR15","first-page":"779","volume":"171","author":"V Giorgi De","year":"2011","unstructured":"De Giorgi V, Grazzini M, Gandini S, Benemei S, Lotti T, Marchionni N, et al. Treatment with beta-blockers and reduced disease progression in patients with thick melanoma. Arch Intern Med. 2011;171:779\u201381.","journal-title":"Arch Intern Med"},{"key":"4420_CR16","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1158\/1055-9965.EPI-11-0249","volume":"20","author":"S Lemeshow","year":"2011","unstructured":"Lemeshow S, S\u00f8rensen HT, Phillips G, Yang EV, Antonsen S, Riis AH, et al. Beta-blockers and survival among Danish patients with malignant melanoma: a population-based cohort study. Cancer Epidemiol Biomark Prev: Publ Am Assoc Cancer Res Cosponsored Am Soc Prev Oncol. 2011;20:2273\u20139.","journal-title":"Cancer Epidemiol Biomark Prev: Publ Am Assoc Cancer Res Cosponsored Am Soc Prev Oncol"},{"key":"4420_CR17","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/labinvest.2012.175","volume":"93","author":"S Moretti","year":"2013","unstructured":"Moretti S, Massi D, Farini V, Baroni G, Parri M, Innocenti S, et al. Beta-adrenoceptors are upregulated in human melanoma and their activation releases pro-tumorigenic cytokines and metalloproteases in melanoma cell lines. Lab Investig: J Tech Methods Pathol. 2013;93:279\u201390.","journal-title":"Lab Investig: J Tech Methods Pathol"},{"key":"4420_CR18","doi-asserted-by":"crossref","unstructured":"Shimizu A, Kaira K, Kato M, Yasuda M, Takahashi A, Tominaga H, et al. Prognostic significance of L-type amino acid transporter 1 (LAT1) expression in cutaneous melanoma. Melanoma Res 2015; in press.","DOI":"10.1097\/CMR.0000000000000181"},{"key":"4420_CR19","doi-asserted-by":"crossref","first-page":"3746","DOI":"10.1200\/JCO.2009.27.4662","volume":"28","author":"K Kaira","year":"2010","unstructured":"Kaira K, Endo M, Abe M, Nakagawa K, Ohde Y, Okumura T, et al. Biologic correlation of 2-[18F]-fluoro-2-deoxy-D-glucose uptake on positron emission tomography in thymic epithelial tumors. J Clin Oncol: Off J Am Soc Clin Oncol. 2010;28:3746\u201353.","journal-title":"J Clin Oncol: Off J Am Soc Clin Oncol"},{"key":"4420_CR20","doi-asserted-by":"crossref","first-page":"3473","DOI":"10.1245\/s10434-009-0685-0","volume":"16","author":"K Kaira","year":"2009","unstructured":"Kaira K, Oriuchi N, Imai H, Shimizu K, Yanagitani N, Sunaga N, et al. CD98 expression is associated with poor prognosis in resected non-small-cell lung cancer with lymph node metastases. Ann Surg Oncol. 2009;16:3473\u201381.","journal-title":"Ann Surg Oncol"},{"key":"4420_CR21","doi-asserted-by":"crossref","first-page":"3863","DOI":"10.1016\/j.ejca.2013.07.141","volume":"49","author":"E Livingstone","year":"2013","unstructured":"Livingstone E, Hollestein LM, van Herk-Sukel MP, van de Poll-Franse L, Nijsten T, Schadendorf D, et al. beta-Blocker use and all-cause mortality of melanoma patients: results from a population-based Dutch cohort study. Eur J Cancer. 2013;49:3863\u201371.","journal-title":"Eur J Cancer"},{"key":"4420_CR22","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1111\/bjd.12894","volume":"170","author":"C McCourt","year":"2014","unstructured":"McCourt C, Coleman HG, Murray LJ, Cantwell MM, Dolan O, Powe DG, et al. Beta-blocker usage after malignant melanoma diagnosis and survival: a population-based nested case-control study. Br J Dermatol. 2014;170:930\u20138.","journal-title":"Br J Dermatol"},{"key":"4420_CR23","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3233\/CBM-2012-0228","volume":"10","author":"DM Bravo-Calderon","year":"2011","unstructured":"Bravo-Calderon DM, Oliveira DT, Marana AN, Nonogaki S, Carvalho AL, Kowalski LP. Prognostic significance of beta-2 adrenergic receptor in oral squamous cell carcinoma. Cancer Biomark: Sect A Dis Mark. 2011;10:51\u20139.","journal-title":"Cancer Biomark: Sect A Dis Mark"},{"key":"4420_CR24","doi-asserted-by":"crossref","first-page":"3556","DOI":"10.1245\/s10434-012-2396-1","volume":"19","author":"D Chen","year":"2012","unstructured":"Chen D, Xing W, Hong J, Wang M, Huang Y, Zhu C, et al. The beta2-adrenergic receptor is a potential prognostic biomarker for human hepatocellular carcinoma after curative resection. Ann Surg Oncol. 2012;19:3556\u201365.","journal-title":"Ann Surg Oncol"},{"key":"4420_CR25","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.acthis.2012.06.009","volume":"115","author":"Y Wenjuan","year":"2013","unstructured":"Wenjuan Y, Yujun L, Ceng Y. Association of single nucleotide polymorphisms of beta2-adrenergic receptor gene with clinicopathological features of pancreatic carcinoma. Acta Histochem. 2013;115:198\u2013203.","journal-title":"Acta Histochem"},{"key":"4420_CR26","doi-asserted-by":"crossref","first-page":"7042","DOI":"10.1158\/0008-5472.CAN-10-0522","volume":"70","author":"EK Sloan","year":"2010","unstructured":"Sloan EK, Priceman SJ, Cox BF, Yu S, Pimentel MA, Tangkanangnukul V, et al. The sympathetic nervous system induces a metastatic switch in primary breast cancer. Cancer Res. 2010;70:7042\u201352.","journal-title":"Cancer Res"},{"key":"4420_CR27","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/ijc.20410","volume":"112","author":"K Lang","year":"2004","unstructured":"Lang K, Drell 4th TL, Lindecke A, Niggemann B, Kaltschmidt C, Zaenker KS, et al. Induction of a metastatogenic tumor cell type by neurotransmitters and its pharmacological inhibition by established drugs. Int J Cancer J Int Cancer. 2004;112:231\u20138.","journal-title":"Int J Cancer J Int Cancer"},{"key":"4420_CR28","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1124\/jpet.107.134528","volume":"326","author":"X Liu","year":"2008","unstructured":"Liu X, Wu WK, Yu L, Li ZJ, Sung JJ, Zhang ST, et al. Epidermal growth factor-induced esophageal cancer cell proliferation requires transactivation of beta-adrenoceptors. J Pharmacol Exp Ther. 2008;326:69\u201375.","journal-title":"J Pharmacol Exp Ther"},{"key":"4420_CR29","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1242\/jcs.02772","volume":"119","author":"CE Pullar","year":"2006","unstructured":"Pullar CE, Isseroff RR. The beta 2-adrenergic receptor activates pro-migratory and pro-proliferative pathways in dermal fibroblasts via divergent mechanisms. J Cell Sci. 2006;119:592\u2013602.","journal-title":"J Cell Sci"},{"key":"4420_CR30","first-page":"151","volume":"23","author":"A Yuan","year":"2010","unstructured":"Yuan A, Li Z, Li X, Yi S, Wang S, Cai Y, et al. The mitogenic effectors of isoproterenol in human hepatocellular carcinoma cells. Oncol Rep. 2010;23:151\u20137.","journal-title":"Oncol Rep"},{"key":"4420_CR31","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/S0962-8924(02)02294-8","volume":"12","author":"PJ Stork","year":"2002","unstructured":"Stork PJ, Schmitt JM. Crosstalk between cAMP and MAP kinase signaling in the regulation of cell proliferation. Trends Cell Biol. 2002;12:258\u201366.","journal-title":"Trends Cell Biol"},{"key":"4420_CR32","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/jid.2014.373","volume":"135","author":"LJ Wrobel","year":"2015","unstructured":"Wrobel LJ, Le Gal FA. Inhibition of human melanoma growth by a non-cardioselective beta-blocker. J Investig Dermatol. 2015;135:525\u201331.","journal-title":"J Investig Dermatol"}],"container-title":["Tumor Biology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13277-015-4420-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13277-015-4420-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13277-015-4420-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13277-015-4420-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T15:43:45Z","timestamp":1559490225000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13277-015-4420-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11,23]]},"references-count":32,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,5]]}},"alternative-id":["4420"],"URL":"https:\/\/doi.org\/10.1007\/s13277-015-4420-0","relation":{},"ISSN":["1010-4283","1423-0380"],"issn-type":[{"value":"1010-4283","type":"print"},{"value":"1423-0380","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,11,23]]}}}